MYC and prostate neoplasm: As publicly available datasets of HIF1A DNA binding sites in prostate tumor cells were scarce, with these analyses performed on human PC-3 cells (21), which are of metastatic origin, and data on murine prostate cells were unavailable (22), we induced HIF1A protein levels in Myc-CaP cells by a 6-hour treatment with DMOG (fig.